| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Departments of Pathology [X. W., K. H. Y. F., J. M. N.], Anatomy [S. C. H. W., J. P., S. W. T.], and Radiation Oncology [D. L. W. K., J. S. T. S.], University of Hong Kong, Queen Mary Hospital, Hong Kong, People's Republic of China
Cellular senescence is a programmed cell response leading to growth arrest in human diploid fibroblasts. We have shown that a nasopharyngeal carcinoma cell line, CNE1, following treatment by the DNA-damaging agent cisplatin, can undergo cellular senescent-like growth arrest, similar to fibroblasts, judged by cellular morphological changes and the expression of senescence-associated ß-galactosidase (SA-ß-gal). This senescent-like change was dose related; at 0.5 µg/ml, the percentage of cisplatin-induced SA-ß-gal-positive cells was high (4096%), and the staining was intense. Higher doses (1.0 and 2.0 µg/ml) of cisplatin induced lower SA-ß-gal expression (3070%), and the process was irreversible. This cisplatin-induced cellular senescent-like response was not due to the inhibition of telomerase activity. Our results indicate that cellular senescent-like pathways exist in nasopharyngeal carcinoma cells and can be induced by cisplatin. Our evidence suggests that cellular senescent-like responses may be a cellular protection mechanism that acts differently in response to different degrees of cellular damage.
1 This work was supported by the Hong Kong Research Grant Council (No. 338/046/0011), the University of Hong Kong (CRCG Grant No. 337/037/0001, 335/037/0002), the Li Ka Shing Foundation, the Hong Kong Jockey Club (Charity) Ltd., the Ho Hung Chiu Foundation, and Croucher Foundation, Hong Kong.
2 To whom requests for reprints should be addressed, at Department of Pathology, University of Hong Kong, Queen Mary Hospital, Pok Fu Lam Road, Hong Kong, People's Republic of China. Phone: (852) 2855 4883; Fax: (852) 2872 5197; E-mail: jmnichol@hkucc.hku.hk.
Received 8/ 6/98. Accepted 9/28/98.
This article has been cited by other articles:
![]() |
W. K. Kwok, M.-T. Ling, H. F. Yuen, Y.-C. Wong, and X. Wang Role of p14ARF in TWIST-mediated senescence in prostate epithelial cells Carcinogenesis, December 1, 2007; 28(12): 2467 - 2475. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. T. Yip, R. Chopra, R. Chakrabarti, M. S. Veena, B. Ramamurthy, E. S. Srivatsan, and M. B. Wang Cisplatin-Induced Growth Arrest of Head and Neck Cancer Cells Correlates With Increased Expression of p16 and p53. Arch Otolaryngol Head Neck Surg, March 1, 2006; 132(3): 317 - 326. [Abstract] [Full Text] [PDF] |
||||
![]() |
W.-S. Xu, G. Perez, L. Ngo, C.-Y. Gui, and P. A. Marks Induction of Polyploidy by Histone Deacetylase Inhibitor: A Pathway for Antitumor Effects Cancer Res., September 1, 2005; 65(17): 7832 - 7839. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. W. Cheung, D.-Y. Jin, M.-t. Ling, Y. C. Wong, Q. Wang, S. W. Tsao, and X. Wang Mitotic Arrest Deficient 2 Expression Induces Chemosensitization to a DNA-Damaging Agent, Cisplatin, in Nasopharyngeal Carcinoma Cells Cancer Res., February 15, 2005; 65(4): 1450 - 1458. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. B. Roninson Tumor Cell Senescence in Cancer Treatment Cancer Res., June 1, 2003; 63(11): 2705 - 2715. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Haq, J. D. Brenton, M. Takahashi, D. Finan, R. Rottapel, and B. Zanke Constitutive p38HOG Mitogen-activated Protein Kinase Activation Induces Permanent Cell Cycle Arrest and Senescence Cancer Res., September 1, 2002; 62(17): 5076 - 5082. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Wang, D.-Y. Jin, Y.C. Wong, A. L.M. Cheung, A. C.S. Chun, A. K.F. Lo, Y. Liu, and S. W. Tsao Correlation of defective mitotic checkpoint with aberrantly reduced expression of MAD2 protein in nasopharyngeal carcinoma cells Carcinogenesis, December 1, 2000; 21(12): 2293 - 2297. [Abstract] [Full Text] [PDF] |
||||
![]() |
B.-D. Chang, E. V. Broude, M. Dokmanovic, H. Zhu, A. Ruth, Y. Xuan, E. S. Kandel, E. Lausch, K. Christov, and I. B. Roninson A Senescence-like Phenotype Distinguishes Tumor Cells That Undergo Terminal Proliferation Arrest after Exposure to Anticancer Agents Cancer Res., August 1, 1999; 59(15): 3761 - 3767. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |